Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jeffrey J Raizer

Showing results (11-20 of 79) with videos related to

Pageof 8
Sort By:
Technology in Cancer Research & Treatment|May 17, 2006
Convection-enhanced and local delivery of targeted cytotoxins in the treatment of malignant gliomasKenji Muro, Sunit Das, Jeffrey J Raizer
Journal of Neuro-Oncology|June 28, 2018
Widespread disseminated osseous metastases of intracranial meningioma with over 27-year-survivorship: a unique, idiosyncratic caseBetty Mishkin, Jeffrey J Raizer, Jonathan B Bell
Journal of Neuro-Oncology|October 16, 2012
Outcome of discontinuing bevacizumab prior to malignant glioma progressionWendy J Sherman, Jeffrey J Raizer, Sean A Grimm
Journal of Neuro-Oncology|February 19, 2005
Isolated primary intracerebral mycetoma: presenting as a mass lesion in a patient with prostate cancer and multiple myelomaShyam Prabhakaran, Philip H Gutin, Andrei Holodny, et al.
Oncology (Williston Park, N.Y.)|March 2, 2018
Primary Central Nervous System Lymphoma-PART 2: Modern Therapeutic Management and Future DirectionsRimas V Lukas, Vinai Gondi, Roger Stupp, et al.
Oncology (Williston Park, N.Y.)|February 16, 2018
Primary Central Nervous System Lymphoma-PART 1: Epidemiology, Diagnosis, Staging, and PrognosisRimas V Lukas, Roger Stupp, Vinai Gondi, et al.
Neuro-Oncology|July 29, 2004
Phase 1 study of 28-day, low-dose temozolomide and BCNU in the treatment of malignant gliomas after radiation therapyJeffrey J Raizer, Mark G Malkin, Martin Kleber, et al.
Journal of Neuro-Oncology|August 2, 2003
Leptomeningeal metastases from recurrent squamous cell cancer of the skinMartin Begemann, Marc K Rosenblum, John Loh, et al.
Journal of Neuro-Oncology|June 27, 2003
Myelopathy from Waldenström's macroglobulinemia: improvement after Rituximab therapyBernardo Liberato, Adrienne Riethmuller, Raymond L Comenzo, et al.
Cancer|July 13, 2002
High-grade gliomas in patients with prior systemic malignanciesFernando C Maluf, Lisa M DeAngelis, Jeffrey J Raizer, et al.
Pageof 8

Showing results (11-20 of 79) with videos related to

Sort By:
Pageof 8
Technology in Cancer Research & Treatment|May 17, 2006
Convection-enhanced and local delivery of targeted cytotoxins in the treatment of malignant gliomasKenji Muro, Sunit Das, Jeffrey J Raizer
Journal of Neuro-Oncology|June 28, 2018
Widespread disseminated osseous metastases of intracranial meningioma with over 27-year-survivorship: a unique, idiosyncratic caseBetty Mishkin, Jeffrey J Raizer, Jonathan B Bell
Journal of Neuro-Oncology|October 16, 2012
Outcome of discontinuing bevacizumab prior to malignant glioma progressionWendy J Sherman, Jeffrey J Raizer, Sean A Grimm
Journal of Neuro-Oncology|February 19, 2005
Isolated primary intracerebral mycetoma: presenting as a mass lesion in a patient with prostate cancer and multiple myelomaShyam Prabhakaran, Philip H Gutin, Andrei Holodny, et al.
Oncology (Williston Park, N.Y.)|March 2, 2018
Primary Central Nervous System Lymphoma-PART 2: Modern Therapeutic Management and Future DirectionsRimas V Lukas, Vinai Gondi, Roger Stupp, et al.
Oncology (Williston Park, N.Y.)|February 16, 2018
Primary Central Nervous System Lymphoma-PART 1: Epidemiology, Diagnosis, Staging, and PrognosisRimas V Lukas, Roger Stupp, Vinai Gondi, et al.
Neuro-Oncology|July 29, 2004
Phase 1 study of 28-day, low-dose temozolomide and BCNU in the treatment of malignant gliomas after radiation therapyJeffrey J Raizer, Mark G Malkin, Martin Kleber, et al.
Journal of Neuro-Oncology|August 2, 2003
Leptomeningeal metastases from recurrent squamous cell cancer of the skinMartin Begemann, Marc K Rosenblum, John Loh, et al.
Journal of Neuro-Oncology|June 27, 2003
Myelopathy from Waldenström's macroglobulinemia: improvement after Rituximab therapyBernardo Liberato, Adrienne Riethmuller, Raymond L Comenzo, et al.
Cancer|July 13, 2002
High-grade gliomas in patients with prior systemic malignanciesFernando C Maluf, Lisa M DeAngelis, Jeffrey J Raizer, et al.
Pageof 8